Cancilico

Cancilico develops AI-powered software, including MyeloAID, for image-based diagnostics focused on hematological cancers. This technology automates the classification and counting of cells in bone marrow smears to provide rapid, accurate analysis. The company offers tailored AI services to enhance precision and efficiency in medical research and clinical workflows.

Traction 6/10

Dresden, Germany · HQ

Founded 20239500+ followers

Artificial Intelligence
Digital Health
Healthcare Technology
Software Only

Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Moritz Middeke

Founder

Product

Features

Cancilico develops AI-powered software, including MyeloAID, for image-based diagnostics focused on hematological cancers. This technology automates the classification and counting of cells in bone marrow smears to provide rapid, accurate analysis. The company offers tailored AI services to enhance precision and efficiency in medical research and clinical workflows.